11 results
The primary goal of this study is to determine discrepancies between INR measurements with Coaguchek XS and Coagulometer in APS patients. The secondary objective is to investigate which antiphospholipid antibodies correlate with the observed INR…
To determine the occurrence and natural history of (subclinical) cardiac abnormalities during hospital admission for COVID-19 and the possible cardiovascular complications short-tem (6 months) and long-term (1,2,5,10 years) post-admission.
Co-primary objectives:Hemorrhagic complicationsPerioperative blood lossPerioperative blood loss is determined by measuring blood recovered in the suction device during surgery and weighting of blood saturated gauzes used during surgery. In case a…
This study has been transitioned to CTIS with ID 2023-506943-40-00 check the CTIS register for the current data. The overall objective of this trial will be to evaluate the efficacy and safety of clinical surveillance without anticoagulation in low-…
To evaluate the prevalence of C-TMA in patients presenting with TMA, either with coexisting conditions or not. Furthermore, (i) the diagnostic performance of an in-house developed ex vivo test, (ii) dynamics of complement measures during follow-up,…
To determine which patients, individually classified for VTE ánd bleeding risk, will benefit from prolonged anticoagulant treatment without being unnecessarily exposed to its risks.
The primary aim of this study is to compare intrinsic pathway activation between cancer patients with acute VTE and those without VTE. Intrinsic pathway activation will be assessed by measuring coagulation factor complexes with their natural…
(1) Determine the prevalence of (asymptomatic) silent brain infarcts among patients with COVID-19 admitted to after discharge (at least <3 months after positive PCR test) from the hospital, compared with healthy controls.(2) Investigate risk…
The purpose of this pilot trial is to determine whether it is feasible to conduct a full multicentre randomized controlled trial (RCT) to determine whether low-dose aspirin (ASA) is efficacious and safe at preventing postpartum venous…
To explore the change in circulating biomarkers of activation of the coagulation system before and after SARS-CoV2 vaccination (AstraZeneca).
The main objectives of this study are(I) to compare the sensitivity of CT-venography and ultrasound for screening-detected, catheter-related thrombosis in cancer patients and (II) to assess intrinsic coagulation levels in cancer patients prior to…